Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Groll, A H; Kolve, H

Groll, A H; Kolve, H.

Affiliation

Groll AH; Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology and Oncology, University Children's Hospital, Domagkstrasse 9a, 48129 Muenster, Germany. grollan@mednet.uni-muenster.de

Eur J Clin Microbiol Infect Dis ; 23(4): 256-70, 2004 Apr.

Article in En | MEDLINE | ID: mdl-15015031

Subject(s)

Antifungal Agents/pharmacokinetics; Drug Resistance, Fungal; Mycoses/drug therapy; Antifungal Agents/therapeutic use; Biological Availability; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Mycoses/diagnosis; Sensitivity and Specificity

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Fungal / Mycoses / Antifungal Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Eur J Clin Microbiol Infect Dis Year: 2004 Document type: Article

Search on Google

XML

PubMed Links